Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.258.15ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.258.15NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.298ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.298ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.298ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.298NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
C.30.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18812.9France
C.30.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
C.30.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
C.30.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.177.76ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.177.76ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.177.76ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.76NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.258.11ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.258.11ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.258.11ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.258.11NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.1.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.1.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.1.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.1.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.160.31ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.160.31ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.160.31ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.160.31NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.385ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.385ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.385ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.385NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.384ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.384ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.384ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.384NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.160.32ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.160.32ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.160.32ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.160.32NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.338ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.338ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.338ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.338NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BG.6ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BG.6ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BG.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BG.6NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
AY.20.1 (Delta)ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AY.20.1 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.20.1 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.20.1 (Delta)NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used